Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 2871

1.

Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.

Machtay M, Lee JH, Stevenson JP, Shrager JB, Algazy KM, Treat J, Kaiser LR.

J Thorac Cardiovasc Surg. 2004 Jan;127(1):108-13.

2.

Phase II trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection: a single-center study.

Friedel G, Budach W, Dippon J, Spengler W, Eschmann SM, Pfannenberg C, Al-Kamash F, Walles T, Aebert H, Kyriss T, Veit S, Kimmich M, Bamberg M, Kohlhaeufl M, Steger V, Hehr T.

J Clin Oncol. 2010 Feb 20;28(6):942-8. doi: 10.1200/JCO.2008.21.7810. Epub 2010 Jan 25.

PMID:
20100967
3.

Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group--RTOG 9705.

Bradley JD, Paulus R, Graham MV, Ettinger DS, Johnstone DW, Pilepich MV, Machtay M, Komaki R, Atkins J, Curran WJ; Radiation Therapy Oncology Group.

J Clin Oncol. 2005 May 20;23(15):3480-7.

PMID:
15908657
4.
5.

Concurrent cisplatin, etoposide, and radiotherapy for unresectable stage III nonsmall cell lung cancer: a phase II study.

Reboul F, Brewer Y, Vincent P, Chauvet B, Faure CF, Taulelle M.

Int J Radiat Oncol Biol Phys. 1996 May 1;35(2):343-50.

PMID:
8635942
6.

Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.

Sonett JR, Suntharalingam M, Edelman MJ, Patel AB, Gamliel Z, Doyle A, Hausner P, Krasna M.

Ann Thorac Surg. 2004 Oct;78(4):1200-5; discussion 1206. Review.

PMID:
15464470
7.

Short-course induction chemoradiotherapy with paclitaxel for stage III non-small-cell lung cancer.

Rice TW, Adelstein DJ, Ciezki JP, Becker ME, Rybicki LA, Farver CF, Larto MA, Blackstone EH.

Ann Thorac Surg. 1998 Dec;66(6):1909-14.

PMID:
9930467
8.

The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.

Milman S, Kim AW, Warren WH, Liptay MJ, Miller C, Basu S, Faber LP.

Ann Thorac Surg. 2009 Sep;88(3):945-50; discussion 950-1. doi: 10.1016/j.athoracsur.2009.05.084.

PMID:
19699925
9.

Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.

Kumar P, Herndon J 2nd, Langer M, Kohman LJ, Elias AD, Kass FC, Eaton WL, Seagren SL, Green MR, Sugarbaker DJ.

Cancer. 1996 Jun 1;77(11):2393-9.

10.

Neoadjuvant chemoradiation with paclitaxel/carboplatin for selected Stage III non-small-cell lung cancer: long-term results of a trimodality Phase II protocol.

Hehr T, Friedel G, Steger V, Spengler W, Eschmann SM, Bamberg M, Budach W.

Int J Radiat Oncol Biol Phys. 2010 Apr;76(5):1376-81. doi: 10.1016/j.ijrobp.2009.03.077. Epub 2009 Oct 26.

PMID:
19864078
11.

Phase II study of neoadjuvant chemotherapy and radiation therapy with thoracotomy in the treatment of clinically staged IIIA non-small cell lung cancer.

Deutsch M, Crawford J, Leopold K, Wolfe W, Foster W, Herndon J, Blackwell S, Yost R.

Cancer. 1994 Aug 15;74(4):1243-52.

13.

Accelerated hyperfractionated radiation, concurrent paclitaxel/cisplatin chemotherapy and surgery for stage III non-small cell lung cancer.

Adelstein DJ, Rice TW, Rybicki LA, Greskovich JF Jr, Ciezki JP, Carroll MA, DeCamp MM.

Lung Cancer. 2002 May;36(2):167-74.

PMID:
11955651
14.

Accelerated induction therapy and resection for poor prognosis stage III non-small cell lung cancer.

Rice TW, Adelstein DJ, Koka A, Tefft M, Kirby TJ, Van Kirk MA, Taylor ME, Olencki TE, Peereboom D, Budd GT.

Ann Thorac Surg. 1995 Sep;60(3):586-91; discussion 591-2.

PMID:
7677484
15.

[Weekly paclitaxel and carboplatin with concurrent three dimensional conformal radiotherapy for locally advanced non small cell lung cancer].

Wang J, Pang QS, Wang P, Wang J, Wang W.

Zhonghua Zhong Liu Za Zhi. 2007 Oct;29(10):769-72. Chinese.

PMID:
18396691
16.

Phase II study of consolidation paclitaxel after concurrent chemoradiation in poor-risk stage III non-small-cell lung cancer: SWOG S9712.

Davies AM, Chansky K, Lau DH, Leigh BR, Gaspar LE, Weiss GR, Wozniak AJ, Crowley JJ, Gandara DR; SWOG S9712.

J Clin Oncol. 2006 Nov 20;24(33):5242-6.

PMID:
17114656
17.

Long-term survival results for patients with locally advanced, initially unresectable non-small cell lung cancer treated with aggressive concurrent chemoradiation.

Langer CJ, Curran WJ, Keller SM, Catalano RB, Litwin S, Blankstein KB, Haas N, Campli SN, Comis RL.

Cancer J Sci Am. 1996 Mar-Apr;2(2):99-105.

PMID:
9166507
18.

Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.

Dillman RO, Herndon J, Seagren SL, Eaton WL Jr, Green MR.

J Natl Cancer Inst. 1996 Sep 4;88(17):1210-5.

PMID:
8780630
19.

Value of accelerated multimodality therapy in stage IIIA and IIIB non-small cell lung cancer.

DeCamp MM, Rice TW, Adelstein DJ, Chidel MA, Rybicki LA, Murthy SC, Blackstone EH.

J Thorac Cardiovasc Surg. 2003 Jul;126(1):17-27.

20.

Supplemental Content

Support Center